Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Irwin Davidson

Showing results (101-110 of 121) with videos related to

Pageof 13
Sort By:
Nature Communications|January 8, 2025
Pan-inhibition of super-enhancer-driven oncogenic transcription by next-generation synthetic ecteinascidins yields potent anti-cancer activityMax Cigrang, Julian Obid, Maguelone Nogaret, et al.
Cell Reports. Medicine|November 15, 2023
Silencing of genes by promoter hypermethylation shapes tumor microenvironment and resistance to immunotherapy in clear-cell renal cell carcinomasXiaofan Lu, Yann-Alexandre Vano, Xiaoping Su, et al.
Cell Death and Differentiation|January 19, 2021
Single-cell RNA sequencing reveals intratumoral heterogeneity in primary uveal melanomas and identifies HES6 as a driver of the metastatic diseaseCharlotte Pandiani, Thomas Strub, Nicolas Nottet, et al.
Molecular Cell|June 13, 2020
Tuning Transcription Factor Availability through Acetylation-Mediated Genomic RedistributionPakavarin Louphrasitthiphol, Robert Siddaway, Alessia Loffreda, et al.
Cell|July 5, 2011
Thymine DNA glycosylase is essential for active DNA demethylation by linked deamination-base excision repairSalvatore Cortellino, Jinfei Xu, Mara Sannai, et al.
Cell Death & Disease|October 24, 2025
SETDB1 is critically required for uveal melanoma growth and represents a promising therapeutic targetImène Krossa, Céline Pisibon, Yann Cheli, et al.
Nature Communications|May 26, 2023
SMARCB1 regulates a TFCP2L1-MYC transcriptional switch promoting renal medullary carcinoma transformation and ferroptosis resistanceBujamin H Vokshi, Guillaume Davidson, Nassim Tawanaie Pour Sedehi, et al.
Cancer Research|June 19, 2023
Mesenchymal-like Tumor Cells and Myofibroblastic Cancer-Associated Fibroblasts Are Associated with Progression and Immunotherapy Response of Clear Cell Renal Cell CarcinomaGuillaume Davidson, Alexandra Helleux, Yann A Vano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2022
An Enhancer Demethylator Phenotype Converged to Immune Dysfunction and Resistance to Immune Checkpoint Inhibitors in Clear-Cell Renal Cell CarcinomasXiaofan Lu, Yann Vano, Alexandra Helleux, et al.
Nature|March 25, 2016
Melanoma addiction to the long non-coding RNA SAMMSONEleonora Leucci, Roberto Vendramin, Marco Spinazzi, et al.
Pageof 13

Showing results (101-110 of 121) with videos related to

Sort By:
Pageof 13
Nature Communications|January 8, 2025
Pan-inhibition of super-enhancer-driven oncogenic transcription by next-generation synthetic ecteinascidins yields potent anti-cancer activityMax Cigrang, Julian Obid, Maguelone Nogaret, et al.
Cell Reports. Medicine|November 15, 2023
Silencing of genes by promoter hypermethylation shapes tumor microenvironment and resistance to immunotherapy in clear-cell renal cell carcinomasXiaofan Lu, Yann-Alexandre Vano, Xiaoping Su, et al.
Cell Death and Differentiation|January 19, 2021
Single-cell RNA sequencing reveals intratumoral heterogeneity in primary uveal melanomas and identifies HES6 as a driver of the metastatic diseaseCharlotte Pandiani, Thomas Strub, Nicolas Nottet, et al.
Molecular Cell|June 13, 2020
Tuning Transcription Factor Availability through Acetylation-Mediated Genomic RedistributionPakavarin Louphrasitthiphol, Robert Siddaway, Alessia Loffreda, et al.
Cell|July 5, 2011
Thymine DNA glycosylase is essential for active DNA demethylation by linked deamination-base excision repairSalvatore Cortellino, Jinfei Xu, Mara Sannai, et al.
Cell Death & Disease|October 24, 2025
SETDB1 is critically required for uveal melanoma growth and represents a promising therapeutic targetImène Krossa, Céline Pisibon, Yann Cheli, et al.
Nature Communications|May 26, 2023
SMARCB1 regulates a TFCP2L1-MYC transcriptional switch promoting renal medullary carcinoma transformation and ferroptosis resistanceBujamin H Vokshi, Guillaume Davidson, Nassim Tawanaie Pour Sedehi, et al.
Cancer Research|June 19, 2023
Mesenchymal-like Tumor Cells and Myofibroblastic Cancer-Associated Fibroblasts Are Associated with Progression and Immunotherapy Response of Clear Cell Renal Cell CarcinomaGuillaume Davidson, Alexandra Helleux, Yann A Vano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2022
An Enhancer Demethylator Phenotype Converged to Immune Dysfunction and Resistance to Immune Checkpoint Inhibitors in Clear-Cell Renal Cell CarcinomasXiaofan Lu, Yann Vano, Alexandra Helleux, et al.
Nature|March 25, 2016
Melanoma addiction to the long non-coding RNA SAMMSONEleonora Leucci, Roberto Vendramin, Marco Spinazzi, et al.
Pageof 13